Literature DB >> 15002643

Clinical use of medical devices in the 'Bermuda Triangle'.

Larry Kessler1, Scott D Ramsey, Sean Tunis, Sean D Sullivan.   

Abstract

The pace of medical technological development shows no sign of abating. Analyzing the effect of major federal health agencies on the availability of such technology is critical. This paper describes functions of three government health agencies: the Centers for Medicare and Medicaid Services (CMS), the Food and Drug Administration (FDA), and the National Institutes of Health (NIH). Certain medical technologies fall into gaps between these agencies, which pose challenges in today's era of demand for evidence-based medicine. We suggest new policy and pragmatic strategies that can close the gaps and move decision making relevant to technology forward more rapidly than is now the case.

Mesh:

Year:  2004        PMID: 15002643     DOI: 10.1377/hlthaff.23.1.200

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  7 in total

1.  Impact of alternative medical device approval processes on costs and health.

Authors:  Benjamin P George; Vinayak Venkataraman; E Ray Dorsey; S Claiborne Johnston
Journal:  Clin Transl Sci       Date:  2014-09-03       Impact factor: 4.689

2.  Barriers to investigator-initiated deep brain stimulation and device research.

Authors:  Michael L Kelly; Donald Malone; Michael S Okun; Joan Booth; Andre G Machado
Journal:  Neurology       Date:  2014-03-26       Impact factor: 9.910

Review 3.  Funding the unfundable: mechanisms for managing uncertainty in decisions on the introduction of new and innovative technologies into healthcare systems.

Authors:  Tania Stafinski; Christopher J McCabe; Devidas Menon
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

4.  Economic implications of potential changes to regulatory and reimbursement policies for medical devices.

Authors:  Shelby D Reed; Alisa M Shea; Kevin A Schulman
Journal:  J Gen Intern Med       Date:  2008-01       Impact factor: 5.128

5.  Off-label prescribing: a call for heightened professional and government oversight.

Authors:  Rebecca Dresser; Joel Frader
Journal:  J Law Med Ethics       Date:  2009       Impact factor: 1.718

Review 6.  Who is responsible for evaluating the safety and effectiveness of medical devices? The role of independent technology assessment.

Authors:  Mitchell D Feldman; Amy J Petersen; Leah S Karliner; Jeffrey A Tice
Journal:  J Gen Intern Med       Date:  2008-01       Impact factor: 5.128

7.  Results availability for analgesic device, complex regional pain syndrome, and post-stroke pain trials: comparing the RReADS, RReACT, and RReMiT databases.

Authors:  Faustine L Dufka; Troels Munch; Robert H Dworkin; Michael C Rowbotham
Journal:  Pain       Date:  2015-01       Impact factor: 7.926

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.